GAPLINC and gastric cancer: Furthermore, another study on gastric cancer revealed that HIF-1α directly activates the transcription of lncRNA GAPLINC, which promotes tumor invasion and drug resistance in gastric cancer by regulating stem cell-related genes such as CD44, suggesting that targeting GAPLINC may improve chemosensitivity (Liu et al., 2016).